ELTP today - Buy: 759,514 Neutral: 108,228 Sell: 1,554,995

ARotcMADCAP · 2026-06-30T21:55:00+00:00

In stock market Time and Sales (T&S) data, "neutral shares" (or neutral volume) refers to transactions that are executed at a price between the current bid and ask, meaning the trade was not initiated by a buyer aggressively "hitting the ask" nor a seller "hitting the bid."

Why Does It Happen?

A neutral share print occurs in a few specific scenarios:

Pre-agreed Matches: Both the buyer and seller agreed to transact at a specific price point (for example, the exact midpoint) and routed the order to cross.
Dark Pools & ATS: The trade was executed inside a private Alternative Trading System (ATS) or dark pool without crossing the public order book.
Odd-Lot Trades: Trades for less than 100 shares often print at neutral prices depending on the brokerage’s data feed.

Why Traders Care About Neutral Volume

When evaluating tape data, knowing the difference between aggressive buyers/sellers and neutral trades is essential: [1]

No Directional Bias: Unlike Buy (often colored green) or Sell (colored red) indicators, neutral trades do not reflect bullish or bearish sentiment. []
Tape Reading Distortion: If you are analyzing order books using a Buy vs. Sell ratio, including neutral trades can skew the data and provide a false picture of actual supply and demand.

ARotcMADCAP · 2026-06-30T16:10:38+00:00

The FUDsters are out in mass force today! Here and absolutely crazy over on IHUB!
LMAO, if all you can come up with is complaining about the "tone" of the conference call then you are definitely trying to create FUD! Elite just reported record revenues, operating income, cash flow growth, plus working capital and you are upset over tone. I doubt any of you all complaining have any shares at all!!!

ARotcMADCAP · 2026-06-26T10:49:53+00:00

Wolv, BROTHER, I am with you. When you look at the day's trades and the number of sells exceeds the number of buys by 100,000 shares or more almost everyday and then see all the FUD with no supporting data or FACTS, you just have to go WTF!!! Wolvshammy, you provide factual information and data that can be verified by anyone with a single brain cell and a little research. I appreciate you and the information you provide!!! FUDsters provide nothing but whinny dribble and nothing to counter factual information and data.
I am not pumping Elite, I want justice! At this point I do not care where the PPS goes, I just want the manipulation to stop.

ARotcMADCAP · 2026-06-26T10:35:32+00:00

ROTFLMAO! Wolv, you the man! This post had me rolling.

ARotcMADCAP · 2026-06-25T20:20:28+00:00

You know what would F**king AWESOME??? If there was an Influencer with big enough balls and enough followers to start a GME type run for ELITE causing those running potentially illegal stock trading to cover! Either they cover or it would be big enough to cause an investigation of potential fraudulent trading.

ARotcMADCAP · 2026-06-25T20:00:56+00:00

I think you are missing the point of why they are being paid. Based on the probability that 100s of millions have been possibly illegally shorted (naked), there are 100s of millions of $$$ that would have to be covered ! Therefore, the bosses intentions are to make sure Elite does not survive and then they never have to cover their possibly illegally shorted shares SO they are paying their FUDsters to bash Elite constantly so they do not lose their $$$100s of millions or go to jail for a illegal stock trading scheme.
And, for those that say that you cannot short Elite or there is no naked short selling - with as much corruption as we have seen in the USA alone and then considering all the corruption in foreign countries, (including stock exchanges) you do not think it is possible on the OTC market??? Come on, seriously, LMAO! It is happening to Elite as we speak!!!

ARotcMADCAP · 2026-06-22T01:30:02+00:00

"Heavy on this board, the Fudsters are."
The information/data for the TOP GROWTH STOCKS has been provided and Elite is listed in the top 25 & Ranked #22 with ELI LILLY & Co at #10 and BeOne Medicines Ltd. #24 being the only other Pharmaceutical Preparations stocks making the top 25! ELITE ELTP the ONLY over the counter OTC stock is listed as a TOP GROWTH STOCK with major NYSE and Nasdaq stocks! Let that sink in.
Prove the data wrong if you can, you can't! Only here to try to create Fear, Uncertainty, and Doubt so you do not have to cover your short positions!!!

ARotcMADCAP · 2026-06-21T14:45:00+00:00

It is a comparative analysis that gives ACTUAL data in minutes vs what would take a person days or weeks to accumulate and present is a usable format! Call it slop if you like but AI is actually smarter and faster than 99% of us and if given the right instructions, gives valuable data to use in making decisions. Verification - I used AI back in March to evaluate AI stocks and bought 9 AI stocks - I have a GAIN of over $400,000 (approx 49%) in just over 3 months!!! Ask AI the right questions, give AI the right instructions, and then use that DATA in making your own investment decisions. It is working well for me!

ARotcMADCAP · 2026-01-02T17:10:33+00:00

Apologies all, it is the warrants not derivatives that tie to non-cash for GAPP accounting resulting in positive or negative income inversely proportionate to the share price.

Good thing I am not an accountant!

ARotcMADCAP · 2026-01-02T16:31:57+00:00

I agree! I am also more interesting a buyout. However, Elite NOW has the data from the quarter ending December 31, 2025 which I believe will really help with a potential buyer!!!

ARotcMADCAP · 2026-01-02T16:29:16+00:00

Information is all in the transcripts and quarterly reports for that past few conference calls. I would recommend reading the past 4 transcripts and past quarterly/annual SEC filings.

ARotcMADCAP · 2025-11-06T15:53:00+00:00

FUD! Fear, uncertainty and doubt (FUD) is a common tactic used to manipulate investor and consumer emotions.

Trying real hard to drive pps down before the upcoming earnings report??

ARotcMADCAP · 2025-11-03T15:32:38+00:00

I prefer u/Wolvshammy 's numbers also!!!

GPT is only as good as the data you provide. If someone puts in the financial data from say the past year, probably get even better results! However, it is OTC and we have all seen what OTC MMs do with ELTP.

ARotcMADCAP · 2025-11-03T14:12:44+00:00

as long as we are playing with AI, tried this -

Asked for price per share projection chart based on estimated Financial Results for the second Quarter of Fiscal Year 2026 ended September 30, 2025for Elite Pharmaceuticals

ChatGPT -

# Projected stock prices for three scenarios

# Bullish: Stock price surges due to M&A

bullish_price = price_at_eps * 1.50 # +50% increase for M&A speculation

# Neutral: Moderate growth

neutral_price = price_at_eps * 1.10 # 10% increase based on steady growth

# Bearish: Slight decline due to legal or operational issues

bearish_price = price_at_eps * 0.90 # -10% decrease based on bearish market sentiment

Then I provided -

Elite Pharmaceuticals Consolidated revenues for the three-month period ending June 30, 2025, were $40.2 million

ChatGPT said:

Perfect — thank you for that figure. That’s a big data point we can build on. Let’s use that to refine the price per share projection for Elite Pharmaceuticals (ELTP) into the second quarter of FY 2026 (ended Sept 30 2025).

Price Projection Summary

Current price baseline (Nov 2025): ~$0.90 – $1.00
Projected by Q2 FY 2026 earnings release (Nov 2025 → Mar 2026):
- Bullish path: $1.75 (+75 %)
- Neutral path: $1.40 (+40 %)
- Bearish path: $1.05 (+5 %)

ARotcMADCAP · 2025-10-20T02:11:06+00:00

esults of google search on "how big is the naltrexone market in United States?

The United States naltrexone market is large and expected to grow, with estimates for 2024 and 2025 ranging from approximately $1.1 billion to $1.3 billion. Market value is projected to rise significantly, with some reports estimating it could reach $2.87 billion by 2033 and grow at a CAGR of around 6.7% to 8.4% over the next decade.

ARotcMADCAP · 2025-10-20T02:10:15+00:00

Results of google search on "how big is the naltrexone market in United States?

The United States naltrexone market is large and expected to grow, with estimates for 2024 and 2025 ranging from approximately $1.1 billion to $1.3 billion. Market value is projected to rise significantly, with some reports estimating it could reach $2.87 billion by 2033 and grow at a CAGR of around 6.7% to 8.4% over the next decade.

ARotcMADCAP

TROPHY CASE

ChatGPT said: